Melatonin 3 mg by Designs for Health — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin B6

10 mg (500% DV)

📊 7.7× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)

RDA 1.3mg This product: 10mg UL 100mg

Melatonin

3 mg

📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)

This product: 3mg UL 10mg

Other Ingredients

Cellulose modified Cellulose Gum Magnesium Stearates Dicalcium Phosphate Silica

Label Claims — Verification

❓ All Other

All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Recommended Use: As a dietary supplement, adults take one tablet twenty minutes before bedtime per day, or as directed by your health care practitioner.

⚠️ Warnings & Precautions

Do not take this product if you suffer from an autoimmune disease, depression, diabetes, or any endocrine disorders. Do not use this product while operating a motorized vehicle or heavy machinery.

KEEP OUT OF REACH OF CHILDREN.

Warning: If pregnant or using a prescription drug, consult your health care practitioner.

🧪 Formulation Notes

Does not contain gluten.

Additional Information

MEL060-1

For Professional Use Only

Guaranteed GMP COMPLIANT Products

Manufactured in an NSF GMP Registered Facility

STORE IN A COOL, DRY PLACE.

Notice: Color, size or shape may appear different between lots.

Product Details

UPC / SKU 8 79452 00058 2

DSLD Entry Date 2013-06-25

Product Type Non-Nutrient/Non-Botanical

Form Tablet or Pill

Brand Designs for Health

DSLD ID 22659

Data Updated 2026-04-11

Research Evidence

291 Research Sources

55 Avg Quality Score

129 Meta Analysis

93 Systematic Review

51 Rct

11 Clinical Trial

2 Other

2 Regulatory Source

1 Openfda Safety

A Interventions for preventing delirium in hospitalised non-ICU patients

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI

A Melatonin for preoperative and postoperative anxiety in adults

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI Cochrane

A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials

Meta Analysis BMJ open 2022

PubMed DOI

B Pharmacological interventions for prevention of weight gain in people with schizophrenia

Meta Analysis The Cochrane database of systematic reviews 2022

PubMed DOI

B Melatonin for pre- and postoperative anxiety in adults

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Prevention of depression in adults with long-term physical conditions

Meta Analysis The Cochrane database of systematic reviews 2021

PubMed DOI

B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

Systematic Review Lancet (London, England) 2022

PubMed DOI

B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis

Meta Analysis BMJ open 2023

PubMed DOI

B Second-generation antidepressants for preventing seasonal affective disorder in adults

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI

B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries

Meta Analysis The Cochrane database of systematic reviews 2021

PubMed DOI

View all evidence for Melatonin →